Literature DB >> 12704133

Unexpected similarities between Bordetella avium and other pathogenic Bordetellae.

Patricia A Spears1, Louise M Temple, David M Miyamoto, Duncan J Maskell, Paul E Orndorff.   

Abstract

Bordetella avium causes an upper respiratory tract disease (bordetellosis) in avian species. Commercially raised turkeys are particularly susceptible. Like other pathogenic members of the genus Bordetella (B. pertussis and B. bronchiseptica) that infect mammals, B. avium binds preferentially to ciliated tracheal epithelial cells and produces similar signs of disease. These similarities prompted us to study bordetellosis in turkeys as a possible nonmammalian model for whooping cough, the exclusively human childhood disease caused by B. pertussis. One impediment to accepting such a host-pathogen model as relevant to the human situation is evidence suggesting that B. avium does not express a number of the factors known to be associated with virulence in the other two Bordetella species. Nevertheless, with signature-tagged mutagenesis, four avirulent mutants that had lesions in genes orthologous to those associated with virulence in B. pertussis and B. bronchiseptica (bvgS, fhaB, fhaC, and fimC) were identified. None of the four B. avium genes had been previously identified as encoding factors associated with virulence, and three of the insertions (in fhaB, bvgS, and fimC) were in genes or gene clusters inferred as being absent or incomplete in B. avium, based upon the lack of DNA sequence similarities in hybridization studies and/or the lack of immunological cross-reactivity of the putative products. We further found that the genotypic arrangements of most of the B. avium orthologues were very similar in all three Bordetella species. In vitro tests, including hemagglutination, tracheal ring binding, and serum sensitivity, helped further define the phenotypes conferred by the mutations. Our findings strengthen the connection between the causative agents and the pathogenesis of bordetellosis in all hosts and may help explain the striking similarities of the histopathologic characteristics of this upper airway disease in avian and mammalian species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704133      PMCID: PMC153266          DOI: 10.1128/IAI.71.5.2591-2597.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Discovery, purification, and characterization of a temperate transducing bacteriophage for Bordetella avium.

Authors:  C B Shelton; D R Crosslin; J L Casey; S Ng; L M Temple; P E Orndorff
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae.

Authors:  F R Mooi; W H Jansen; H Brunings; H Gielen; H G van der Heide; H C Walvoort; P A Guinee
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

3.  Characterization of a Bordetella pertussis fimbrial gene cluster which is located directly downstream of the filamentous haemagglutinin gene.

Authors:  R J Willems; H G van der Heide; F R Mooi
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

4.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

5.  Use of bacteriophage Ba1 to identify properties associated with Bordetella avium virulence.

Authors:  Celia B Shelton; Louise M Temple; Paul E Orndorff
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene.

Authors:  R J Willems; C Geuijen; H G van der Heide; M Matheson; A Robinson; L F Versluis; R Ebberink; J Theelen; F R Mooi
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

8.  Observations on Alcaligenes faecalis infection in turkeys.

Authors:  Y M Saif; P D Moorhead; R N Dearth; D J Jackwood
Journal:  Avian Dis       Date:  1980 Jul-Sep       Impact factor: 1.577

9.  Streptococcus-zebrafish model of bacterial pathogenesis.

Authors:  Melody N Neely; John D Pfeifer; Michael Caparon
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.

Authors:  C R Gentry-Weeks; B T Cookson; W E Goldman; R B Rimler; S B Porter; R Curtiss
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

View more
  16 in total

1.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

Review 2.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

3.  Identification and characterization of two Bordetella avium gene products required for hemagglutination.

Authors:  Louise M Temple; David M Miyamoto; Manju Mehta; Christian M Capitini; Stephen Von Stetina; H John Barnes; Vern L Christensen; John R Horton; Patricia A Spears; Paul E Orndorff
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

Review 4.  Bioinformatics annotation of the hypothetical proteins found by omics techniques can help to disclose additional virulence factors.

Authors:  Sergio Hernández; Antonio Gómez; Juan Cedano; Enrique Querol
Journal:  Curr Microbiol       Date:  2009-07-28       Impact factor: 2.188

5.  Bordetella avium causes induction of apoptosis and nitric oxide synthase in turkey tracheal explant cultures.

Authors:  David M Miyamoto; Kristin Ruff; Nathan M Beach; Stephanie B Stockwell; Angella Dorsey-Oresto; Isaac Masters; Louise M Temple
Journal:  Microbes Infect       Date:  2011-05-12       Impact factor: 2.700

6.  Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis, and B. parapertussis reveals extensive diversity in surface structures associated with host interaction.

Authors:  Mohammed Sebaihia; Andrew Preston; Duncan J Maskell; Holly Kuzmiak; Terry D Connell; Natalie D King; Paul E Orndorff; David M Miyamoto; Nicholas R Thomson; David Harris; Arlette Goble; Angela Lord; Lee Murphy; Michael A Quail; Simon Rutter; Robert Squares; Steven Squares; John Woodward; Julian Parkhill; Louise M Temple
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  The Bordetella avium BAV1965-1962 fimbrial locus is regulated by temperature and produces fimbriae involved in adherence to turkey tracheal tissue.

Authors:  Stewart B Loker; Louise M Temple; Andrew Preston
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

9.  Prevalence, virulence attributes, and antibiogram of Bordetella avium isolated from turkeys in Egypt.

Authors:  Walaa Fathy Saad Eldin; Lammah K Abd-El Samie; Wageh Sobhy Darwish; Yaser Hosny A Elewa
Journal:  Trop Anim Health Prod       Date:  2019-08-02       Impact factor: 1.559

Review 10.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.